DSpace Home
→
Fakülteler / Faculties
→
Tıp Fakültesi
→
Dahili Tıp Bilimleri / Internal Medıcal Scıences
→
Makale Koleksiyonu
→
Browsing Makale Koleksiyonu by Author

Browsing Makale Koleksiyonu by Author "Muhittin Ertilav"

Now showing items 1-6 of 6

DOES IMMUNOSUPPRESSIVE TREATMENT AMELIORATE MORPHOLOGY CHANGES IN ENCAPSULATING PERITONEAL SCLEROSIS?

Devrim Bozkurt; Sipahi, Savaş; Pinar Cetin; Ender Hur; Ozden Ozdemir; Muhittin Ertilav; Sait Sen; Duman, Soner (MULTIMED INC, 2009)

Immunosuppressive therapies, especially those that are corticosteroid-based, may have therapeutic value in the management of EPS. Patients treated with cyclosporin may have a risk for developing EPS.
Glycated hemoglobin predicts overall and cardiovascular mortality in non-diabetic hemodialysis patients

Ebru Sevinc Ok; Gulay Asci; Huseyin Toz; Eberhard Ritz; Fatih Kircelli; Mehmet Sukru Sever; Mehmet Ozkahya; Sipahi, Savaş; Dheir, Hamad; Devrim Bozkurt; Ziya Omer; Osman Z. Sahin; Muhittin Ertilav; Ercan Ok (DUSTRI-VERLAG DR KARL FEISTLE, 2014)

Aims: Besides diabetic patients, glycated hemoglobin (HbA(1c)) levels have been reported to predict mortality in non-diabetics patients. However, the importance of HbA(1c) levels in non-diabetic hemodialysis patients still ...
Neither oxidized nor anti-oxidized low-density lipoprotein level is associated with atherosclerosis or mortality in hemodialysis patients

Ebru Sevinc Ok; Fatih Kircelli; Gulay Asci; Ekrem Altunel; Muhittin Ertilav; Sipahi, Savaş; Devrim Bozkurt; Duman, Soner; Mehmet Ozkahya; Huseyin Toz; Ercan Ok (WILEY, 2012)

It is anticipated that oxidized low-density lipoprotein (oxLDL) and anti-oxLDL are associated with atherosclerosis and mortality. However, data on this issue are controversial and limited. We aimed to investigate the effect ...
Octreotide lessens peritoneal injury in experimental encapsulated peritoneal sclerosis model

Muhittin Ertilav; Ender Hur; Devrim Bozkurt; Sipahi, Savaş; Ozge Timur; Banu Sarsik; Fehmi Akcicek; Duman, Soner (WILEY-BLACKWELL, 2011)

Conclusion: In conclusion, octreotide may have a therapeutic value in peritoneal dialysis patients who suffer from encapsulated peritoneal sclerosis.
The association between HbA1c levels and cardiovascular diseases in non-diabetic peritoneal dialysis patients

Dheir, Hamad; Huseyin Toz; Gulay Asci; Duman, Soner; Muhittin Ertilav; Fatih Kircelli; Ebru Gunay Sevinc; Sipahi, Savaş; Meltem Sezis; Timur Kose; Ercan Ok; Mehmet Ozkahya (OXFORD UNIV PRESS, 2007)
The Impact of Membrane Permeability and Dialysate Purity on Cardiovascular Outcomes

Gulay Asci; Huseyin Toz; Mehmet Ozkahya; Duman, Soner; Meltem Sezis Demirci; Mustafa Cirit; Sipahi, Savaş; Dheir, Hamad; Devrim Bozkurt; Fatih Kircelli; Ebru Sevinc Ok; Sinan Erten; Muhittin Ertilav; Timur Kose; Ali Basci; Jochen G. Raimann; Nathan W. Levin; Ercan Ok (AMER SOC NEPHROLOGY, 2013)

The effects of high-flux dialysis and ultrapure dialysate on survival of hemodialysis patients are incompletely understood. We conducted a randomized controlled trial to investigate the effects of both membrane permeability ...